Literature DB >> 12832877

Excision margins for nonmelanotic skin cancer.

Damon J Thomas1, Alan R King, Bruce G Peat.   

Abstract

Scientific evidence for advisable excision margins for nonmelanotic skin carcinoma is poorly documented. Recommended excision margins vary from 2 to 15 mm. A prospective study was performed on 150 skin lesions excised over a 9-month period in an outpatient facility at the authors' institution. Primary nonmelanotic skin lesions were clinically diagnosed as either basal cell carcinoma (nodular, superficial, infiltrating, or sclerosing) or squamous cell carcinoma (well, moderately, or poorly differentiated). Macroscopic surgical excision margins were individually assessed, measured, and excised. Histopathologic analysis was then independently performed to determine the correct diagnosis and to measure the actual microscopic lateral and deep excision margins.Sixty-one percent of lesions were basal cell carcinoma, 25 percent were squamous cell carcinoma, and 15 percent were benign or premalignant. Diagnostic accuracy was 81 percent for basal cell and 59 percent for squamous cell carcinoma. The average diameter of the basal cell carcinoma was 12.1 mm; 47 percent of these lesions had a diameter of less than 10 mm. The average diameter of the squamous cell carcinoma was 16.9 mm; 26 percent of these lesions had a diameter of less than 10 mm. The mean surgical margin was 4.2 mm (3.2 mm adjusted for shrinkage), whereas the mean microscopic lateral margin was 3.4 mm. Overall, complete excision was achieved for 98 percent of basal cell carcinoma and 100 percent of squamous cell carcinoma. The raw data were analyzed to assess the suitability of 1-, 2-, 3-, or 4-mm surgical excision margins. A 4-mm surgical margin would give a microscopic lateral margin beyond one microscopic high-power field (0.5 mm) in 96 percent of cases of basal cell carcinoma and in 97 percent of cases of squamous cell carcinoma. The authors recommend a 4-mm surgical margin as the optimal treatment for skin lesions clinically diagnosed as basal cell or squamous cell carcinoma that are suitable for excision in an outpatient facility. Well-demarcated lesions, such as a nodular basal cell carcinoma, may be excised with a 3-mm margin.

Entities:  

Mesh:

Year:  2003        PMID: 12832877     DOI: 10.1097/01.PRS.0000067479.77859.31

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  28 in total

Review 1.  Bilateral hand squamous-cells carcinoma in patient affected with non-Hodgkin lymphoma. Case report and literature review.

Authors:  P Fino; A M Spagnoli; M Ruggieri; M Marcasciano; N Scuderi
Journal:  G Chir       Date:  2015 Jul-Aug

Review 2.  Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature.

Authors:  Stuart Enoch; David R Miller; Patricia E Price; Keith G Harding
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

3.  Reconstruction of a recurrent first dorsal web space defect using acellular dermis.

Authors:  John Y S Kim; Donald W Buck; Oliver Kloeters; SuRak Eo; Neil F Jones
Journal:  Hand (N Y)       Date:  2007-08-22

Review 4.  Squamous cell carcinoma of the skin (non-metastatic).

Authors:  Adèle C Green; Penelope McBride
Journal:  BMJ Clin Evid       Date:  2010-05-04

5.  Rapid visualization of nonmelanoma skin cancer.

Authors:  Ethan Walker; Margaret Mann; Kord Honda; Allison Vidimos; Mark D Schluchter; Brian Straight; Matthew Bogyo; Daniel Popkin; James P Basilion
Journal:  J Am Acad Dermatol       Date:  2016-11-19       Impact factor: 11.527

6.  Semi-Autonomous Electrosurgery for Tumor Resection Using a Multi-Degree of Freedom Electrosurgical Tool and Visual Servoing.

Authors:  Justin D Opfermann; Simon Leonard; Ryan S Decker; Nicholas A Uebele; Christopher E Bayne; Arjun S Joshi; Axel Krieger
Journal:  Rep U S       Date:  2017-12-14

Review 7.  Squamous cell carcinoma of the skin (non-metastatic).

Authors:  Adèle C Green; Penelope McBride
Journal:  BMJ Clin Evid       Date:  2014-08-18

8.  Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.

Authors:  C Hope Heath; Nicholas L Deep; Lauren N Beck; Kristine E Day; Larissa Sweeny; Kurt R Zinn; Conway C Huang; Eben L Rosenthal
Journal:  Otolaryngol Head Neck Surg       Date:  2013-03-22       Impact factor: 3.497

9.  Paradigm change in the treatment of non-melanoma skin cancer of the auricle: reconstruction with full thickness skin grafting instead of wedge excision.

Authors:  J F Petersen; P A Borggreven; V C M Koot; M J A M Tegelberg; P J F M Lohuis
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-29       Impact factor: 2.503

Review 10.  Skin cancers and dermal substitutes: Is it safe? Review of the literature and presentation of a 2-stage surgical protocol for the treatment of non-melanoma skin cancers of the head in fragile patients.

Authors:  Marco Marcasciano; Marco Mazzocchi; Juste Kaciulyte; Noemi Spissu; Donato Casella; Diego Ribuffo; Luca Andrea Dessy
Journal:  Int Wound J       Date:  2018-06-04       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.